SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Astellas Pharma US Submits Supplemental New Drug Application to FDA for Tarceva® as a First-Line Therapy in Genetically Distinct Form of Non-Small Cell Lung Cancer